SCHEMBL7214906

SCHEMBL7214906

CCCCc1noc(-c2ccc(C(=O)O)cc2)n1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.57
MAPT P10636 3/20 0.57
NPC1 O15118 2/20 0.57
RAB9A P51151 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
KDM4E B2RXH2 1/20 0.57
PKM P14618 1/20 0.57
HPGD P15428 1/20 0.57
HSD17B10 Q99714 1/20 0.57
RARB P10826 6/20 0.54
NR1H4 Q96RI1 1/20 0.51
CHRM2 P08172 2/20 0.48
CHRM4 P08173 2/20 0.48
CHRM5 P08912 2/20 0.48
CHRM1 P11229 2/20 0.48
CHRM3 P20309 2/20 0.48
S1PR1 P21453 2/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2452288 0.85 NR1H4 (0.56) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL7214955 0.85 MAPT (0.55) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL7213208 0.79 SPHK2 (0.48) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL7213201 0.77 TDP1 (0.51) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL6423837 0.76 SPHK1 (0.65) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL23698059 0.76 MGLL (0.51) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL12171137 0.76 ALDH1A1 (0.58) ALDH1A1NPC1RAB9ASMN1; SMN2RARB
SCHEMBL12117878 0.75 NPC1 (0.54) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL2350982 0.75 RARB (0.70) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL6801607 0.74 TPH1 (0.57) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022180080-A1 ANTI-PROLIFERATIVE AGENTS FIRST HEALTH PHARMACEUTICALS B.V. (NL) 2022-09-01 WO disclosed
US-6624309-B1 Administering 4-heterocyclicbenzamide derivative BRISTOL-MYERS SQUIBB COMPANY 2003-09-23 US disclosed
US-20020137968-A1 Benzoic acid derivatives and related compounds as antiarrhythmic agents LLOYD JOHN (US) 2002-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020137968-A1 Benzoic acid derivatives and related compounds as antiarrhythmic agents SCN1A, SCN1B, NR0B1 ALDH1A1 171/4885MAPT 4755/4885NPC1 531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.